NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies said on Friday that it has received notification from the Nasdaq that its stock faces delisting for failing to meet the exchange's $1 minimum bid price requirement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.